Praetorian Group

Your DIOR boutique at New York selling Women's Ready-to-wear, Leather Goods with Accessories

BioNTech SE is a global leader in immunotherapy, dedicated to translating scientific research into effective treatments for cancer and infectious diseases through innovative approaches, including mRNA vaccines. Founded by scientists and physicians, the company emphasizes scientific rigor and operational excellence in its mission to improve global health. With a diverse oncology portfolio and a focus on individualized therapies, BioNTech is pioneering next-generation immunomodulators and targeted treatments to enhance cancer care. The company also aims to leverage its mRNA technology, proven effective in COVID-19 vaccines, to address a variety of infectious diseases, furthering its commitment to combat significant health challenges worldwide. Generated from the website

Acacia Research Corporation develops, acquires and licenses various patented technologies. The company controls more than 100 patent portfolios that include aligned wafer bonding, automated tax reporting, computer graphics, database management, electronic securities trading, fluid flow control and monitoring and medical image stabilization. It also maintains microprocessor enhancement, optical switching, rule based monitoring, vehicle maintenance and wireless digital messaging patent portfolios. Acacia Research Corporation operates Acacia Technologies group, which develops, acquires and licenses patented technologies for the advertising, communications, consumer electronics, database, digital media and semiconductor industries. Its licensees include Hewlett-Packard, Mitsubishi, Samsung, Sanyo, Sharp, Toshiba, Thomson and Walt Disney Company.